Indicators of metabolic syndrome in normotensive normoglycemic asthmatic patients
Background: Pathophysiology of hypertension and bronchial asthma (BA) share many similarities, especially those related to the metabolic syndrome (MS). Aim In this study, the indicators of the MS were evaluated in normoglycemic normotensive asthmatic patients in order to clarify if the components of the MS can still interact to increase the risk of BA, provided that blood pressure and glucose level are kept within the normal physiological ranges.
Methods: Body mass index (BMI), waist circumference (WC), mean arterial blood pressure (MABP), fasting blood glucose (FBG) and insulin (FBI) levels, the quantitative insulin sensitivity check index (QUICKI), serum lipid profile and spirometric measurements were all compared between 120 asthmatic patients and 59 non–asthmatic subjects. Cigarette smoking, pregnancy, age below 20 years or above 40 years, diabetes mellitus and hypertension and other chronic diseases were excluded from all studied groups.
Results: Asthmatic patients demonstrated higher WC (median (25th –75th interquartile) = 88.50 (78.00-101.75), FBI (19.98 (11.12- 40.14), triglyceride level (109.5 (76.50- 134.0)) compared with non-asthmatic subjects (81.00 (72.00-92.00), 13.78 (8.84- 30.24), 89.00 (64.25- 104), P < 0.05). QUICKI and MABP were lower in asthmatic patients (0.310 (0.283- 0.338), 86.66 (83.33- 93.33)) compared with non-asthmatic subjects (0.320 (0.297- 0.353), 93.33 (83.33- 93.33)), P < 0.05). BMI, FBG, LDL, HDL, and total cholesterol levels were comparable in the studied groups.
Conclusions: The present finding gives further evidence for higher WC, FBI, triglyceride level and insulin resistance in in normotensive, normoglycemic asthmatic patients compared to healthy controls.
Relevance for patients: The findings of this study suggested that abdominal obesity, hypertriglyceridemia, hyperinsulinemia and insulin resistance may still be interacting and hence increase the risk of BA in normotensive, normoglycemic subjects.
[1] Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic Syndrome: Pathophysiology, Management, and Modulation by Natural Compounds. Ther Adv Cardiovasc Dis 2017;11:215-25.
[2] Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep 2018;20:12.
[3] Baffi CW, Wood L, Winnica D, Strollo PJ, Gladwin MT, Que LG, et al. Metabolic Syndrome and the Lung. Chest 2016;149:1525-34.
[4] Kankaanranta H, Kauppi P, Tuomisto LE, Ilmarinen P. Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms. Mediators Inflamm 2016;2016:3690628.
[5] Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, et al. Association of the Metabolic Syndrome with Pulmonary Venous Hypertension. Chest 2009;136:31-6.
[6] Paulin R, Michelakis ED. The Metabolic Theory of Pulmonary Arterial Hypertension. Circ Res 2014;115:148-64.
[7] Parish JM, Adam T, Facchiano L. Relationship of Metabolic Syndrome and Obstructive Sleep Apnea. J Clin Sleep Med 2007;3:467-72.
[8] Cazzola M, Calzetta L, Rogliani P, Lauro D, Novelli L, Page CP, et al. High Glucose Enhances Responsiveness of Human Airways Smooth Muscle Via the Rho/ROCK Pathway. Am J Respir Cell Mol Biol 2012;47:509-16.
[9] Hsiao YT, Cheng WC, Liao WC, Lin CL, Shen TC, Chen WC, et al. Type 1 Diabetes and Increased Risk of Subsequent Asthma: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) 2015;94:e1466.
[10] Viardot A, Grey ST, Mackay F, Chisholm D. Potential Antiinflammatory Role of Insulin Via the Preferential Polarization of Effector T Cells Toward a T Helper 2 Phenotype. Endocrinology 2007;148:346-53.
[11] Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-Helper Type 2-Driven Inflammation Defines Major Subphenotypes of Asthma. Am J Respir Crit Care Med 2009;180:388-95.
[12] Sélam JL. Inhaled Insulin: Promises and Concerns. J Diabetes Sci Technol 2008;2:311-5.
[13] Forno E, Han YY, Muzumdar RH, Celedón JC. Insulin Resistance, Metabolic Syndrome, and Lung Function in US Adolescents with and without Asthma. J Allergy Clin Immunol 2015;136:304-11.e8.
[14] Kim KM, Kim SS, Lee SH, Song WJ, Chang YS, Min KU, et al. Association of Insulin Resistance with Bronchial Hyperreactivity. Asia Pac Allergy 2014;4:99-105.
[15] Karampatakis N, Karampatakis T, Galli-Tsinopoulou A, Kotanidou EP, Tsergouli K, Eboriadou-Petikopoulou M, et al. Impaired Glucose Metabolism and Bronchial Hyperresponsiveness in Obese Prepubertal Asthmatic Children. Pediatr Pulmonol 2017;52:160-6.
[16] Ferguson S, Teodorescu MC, Gangnon RE, Peterson AG, Consens FB, Chervin RD, et al. Factors Associated with Systemic Hypertension in Asthma. Lung 2014;52:160-6.
[17] Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, et al. Vascular Smooth Muscle Contraction in Hypertension. Cardiovasc Res 2018;114:529-39.
[18] Bara I, Ozier A, Tunon De Lara JM, Marthan R, Berger P. Pathophysiology of Bronchial Smooth Muscle Remodelling in Asthma. Eur Respir J 2010;36:1174-84.
[19] Mickleborough TD, Gotshall RW. Dietary Salt Intake as a Potential Modifier of Airway Responsiveness in Bronchial Asthma. J Altern Complement Med 2004;10:633-42.
[20] Weinberger MH. Salt Sensitivity of Blood Pressure in Humans. Hypertension 1996;27:481-90.
[21] Underwood PC, Adler GK. The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans. Curr Hypertens Rep 2013;15:59-70.
[22] Ferrannini E, Cushman WC. Diabetes and Hypertension: The Bad Companions. Lancet 2012;380:601-10.
[23] Ramsay SG, Dagg KD, McKay IC, Lipworth BJ, McSharry C, Thomson NC. Investigations on the ReninAngiotensin System in Acute Severe Asthma. Eur Respir J 1997;10:2766-71.
[24] Millar EA, Angus RM, Hulks G, Morton JJ, Connell JMC, Thomson NC. Activity of the Renin-Angiotensin System in Acute Severe Asthma and the Effect of Angiotensin II on Lung Function. Thorax 1994;49:492-5.
[25] Sin DD, Jones RL, Paul Man SF. Obesity is a Risk Factor for Dyspnea but not for Airflow Obstruction. Arch Intern Med 2002;162:1477-81.
[26] Seidell JC, de Groot LC, van Sonsbeek JL, Deurenberg P, Hautvast JG. Associations of Moderate and Severe Overweight with Self-Reported Illness and Medical Care in Dutch Adults. Am J Public Health 1986;76:264-9.
[27] Camargo CA, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective Study of Body Mass Index, Weight Change, and Risk of Adult-Onset Asthma in Women. Arch Intern Med 1999;159:2582-8.
[28] Von Behren J, Lipsett M, Horn-Ross PL, Delfino RJ, Gilliland F, McConnell R, et al. Obesity, Waist Size and Prevalence of Current Asthma in the California Teachers Study Cohort. Thorax 2009;64:889-93.
[29] Brumpton B, Langhammer A, Romundstad P, Chen Y, Mai XM. General and Abdominal Obesity and Incident Asthma in Adults: The Hunt Study. Eur Respir J 2013;41:323-9.
[30] Sood A, Shore SA. Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies. J Allergy (Cairo) 2013;2013:785835.
[31] Jia CE, Zhang HP, Lv Y, Liang R, Jiang YQ, Powell H, et al. The Asthma Control Test and Asthma Control Questionnaire for Assessing Asthma Control: Systematic Review and Meta-Analysis. J Allergy Clin Immunol 2013;131:695-703.
[32] Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma Control Test: Reliability, Validity, and Responsiveness in Patients not Previously Followed by Asthma Specialists. J Allergy Clin Immunol 2006;117:549-56.
[33] Lutfi MF. Patterns of Heart Rate Variability and Cardiac Autonomic Modulations in Controlled and Uncontrolled Asthmatic Patients. BMC Pulm Med 2015;15:119.
[34] Lutfi M. Autonomic Modulations in Patients with Bronchial Asthma Based on Short-Term Heart Rate Variability. Lung India 2012;29:254-8.
[35] Lutfi MF. The Physiological Basis and Clinical Significance of Lung Volume Measurements. Multidiscip Respir Med 2017;12:3.
[36] Latos P, Wojtczak AB. Use of the Glucose Oxidase/ Peroxidase Method for Glucose Assay Leads to Overestimation of the Inhibition of Gluconeogenesis by Aminopyrine. Biochim Biophys Acta 1989;991:152-4.
[37] Warnken T, Huber K, Feige K. Comparison of Three Different Methods for the Quantification of Equine Insulin. BMC Vet Res 2016;12:196.
[38] Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity in Humans. J Clin Endocrinol Metab 2000;85:2402-10.
[39] Akinlade KS, Habila KG, Rahamon SK, Ogundeji OA. Insulin Sensitivity and Mortality Risk Estimation in Patients with Type 2 Diabetes Mellitus. Niger J Clin Pract 2017;20:767-73.
[40] Kayamori Y, Hatsuyama H, Tsujioka T, Nasu M, Katayama Y. Endpoint Colorimetric Method for Assaying Total Cholesterol in Serum with Cholesterol Dehydrogenase. Clin Chem 1999;45:2158-63.
[41] Kalia V, Pundir CS. Determination of Serum Triglycerides Using Lipase, Glycerol Kinase, Glycerol-3-Phosphate Oxidase and Peroxidase Co-Immobilized onto Alkylamine Glass Beads. Indian J Biochem Biophys 2004;41:326-8.
[42] Zhao W, Chaffin C, Desmond RA, Hodges B, Daly TM, Robinson CA, et al. Overestimation of HDL-Cholesterol Using a Homogeneous Direct Assay. J Clin Lab Anal 2004;18:42-4.
[43] Krishnaveni P, Gowda VM. Assessing the Validity of Friedewald’s Formula and Anandraja’s Formula for Serum LDL-Cholesterol Calculation. J Clin Diagn Res 2015;9:BC01-4.
[44] Luder E, Ehrlich RI, Lou WY, Melnik TA, Kattan M. Body Mass Index and the Risk of Asthma in Adults. Respir Med 2004;98:29-37.
[45] Celedón JC, Palmer LJ, Litonjua AA, Weiss ST, Wang B, Fang Z, et al. Body Mass Index and Asthma in Adults in Families of Subjects with Asthma in Anqing, China. Am J Respir Crit Care Med 2001;164:1835-40.
[46] Chinn S, Jarvis D, Burney P. Relation of Bronchial Responsiveness to Body Mass Index in the ECRHS. Thorax 2002;57:1028-33.
[47] Salako BL, Ajayi SO. Bronchial Asthma: A Risk Factor for Hypertension? Afr J Med Med Sci 2000;29:47-50.
[48] Lutfi M, Sukkar M. Hypertensive Effect of Bronchial Asthma. Sudan J Med Sci 2010;5:85-9.
[49] Wisecup S, Eades S, Hashmi SS, Samuels C, Mosquera RA. Diastolic Hypotension in Pediatric Patients with Asthma Receiving Continuous Albuterol. J Asthma 2015;52:693-8.
[50] Sarnaik SM, Saladino RA, Manole M, Pitetti RA, Arora G, Kuch BA, et al. Diastolic Hypotension is an Unrecognized Risk Factor for β-Agonist-Associated Myocardial Injury in Children with Asthma. Pediatr Crit Care Med 2013;14:e273-9.
[51] Zhao H, Song X, Yan L, Ren M, Cui X, Li Y, et al. IgE Induces Hypotension in Asthma Mice by DownRegulating Vascular NCX1 Expression through Activating MiR-212-5p. Biochim Biophys Acta Mol Basis Dis 2018;1864:189-96.
[52] Jiménez JS, Espinet FJ, Garrido JM, Antonio JR, Mayor SP, Boira MM, et al. Asthma and Insulin Resistance in Obese Children and Adolescents. Pediatr Allergy Immunol 2014;25:699-705.
[53] Sakai H, Nishizawa Y, Nishimura A, Chiba Y, Goto K, Hanazaki M, et al. Angiotensin II Induces Hyperresponsiveness of Bronchial Smooth Muscle Via an Activation of p42/44 ERK in Rats. Pflugers Arch 2010;460:645-55.
[54] Yonas MA, Lange NE, Celedón JC. Psychosocial Stress and Asthma Morbidity. Curr Opin Allergy Clin Immunol 2012;12:202-10.
[55] Zhang J, Ren C, Chen L, Navedo MF, Antos LK, Kinsey SP, et al. Knockout of Na+/Ca2+ Exchanger in Smooth Muscle Attenuates Vasoconstriction and L-Type Ca2+ Channel Current and Lowers Blood Pressure. Am J Physiol Heart Circ Physiol 2010;298:H1472-83.
[56] Lutfi M, Sukkar M. The Hyperglycemic Effect of Bronchial Asthma. Sudan Med J 2011;47:69-74.
[57] Canis R, Demirkok SS, Osar Z, Balci H, Can G. Effects of Inhaled Budesonide on Insulin Sensitivity in Nondiabetic Patients with Asthma and Chronic Obstructive Pulmonary Disease. Adv Ther 2007;24:560-70.
[58] Azad MB, Becker AB, Kozyrskyj AL. Association of Maternal Diabetes and Child Asthma. Pediatr Pulmonol 2013;48:545-52.
[59] Arnolds S, Heise T. Inhaled Insulin. Best Pract Res Clin Endocrinol Metab 2007;22:7.
[60] Oleck J, Kassam S, Goldman JD. Commentary: Why was Inhaled Insulin a Failure in the Market? Diabetes Spectr 2016;29:180-4.
[61] Singh S, Prakash YS, Linneberg A, Agrawal A. Insulin and the Lung: Connecting Asthma and Metabolic Syndrome. J Allergy (Cairo) 2013;2013:627384.
[62] Grover A, Padginton C, Wilson MF, Sung BH, Izzo JL, Dandona P. Insulin Attenuates NorepinephrineInduced Venoconstriction: An Ultrasonographic Study. Hypertension 1995;25:779-84.
[63] Steinberg HO, Brechtel G, Johnson A, Fineberg N, BaronAD. Insulin-Mediated Skeletal Muscle Vasodilation is Nitric Oxide Dependent: A Novel Action of Insulin to Increase Nitric Oxide Release. J Clin Invest 1994;94:1172-9.
[64] Sun Q, Li J, Gao F. New Insights into Insulin: The AntiInflammatory Effect and its Clinical Relevance. World J Diabetes 2014;5:89-96.
[65] Dandona P, Chaudhuri A, Mohanty P, Ghanim H. AntiInflammatory Effects of Insulin. Curr Opin Clin Nutr Metab Care 2007;10:511-7.
[66] van Zelst C, De Boer G, Tramper G, Braunstahl GJ. Relations between Serum Lipid Levels and Inflammatory Markers in Obese Asthma. Eur Respir J 2018;52:PA663.
[67] Ko SH, Jeong J, Baeg MK, Han KD, Kim HS, Yoon JS, et al. Lipid Profiles in Adolescents with and Without Asthma: Korea National Health and Nutrition Examination Survey Data. Lipids Health Dis 2018;17:158.
[68] Chen YC, Tung KY, Tsai CH, Su MW, Wang PC, Chen CH, et al. Lipid Profiles in Children with and without Asthma: Interaction of Asthma and Obesity on Hyperlipidemia. Diabetes Metab Syndr 2013;7:20-5.
[69] Ramaraju K, Krishnamurthy S, Maamidi S, Kaza AM, Balasubramaniam N. Is Serum Cholesterol a Risk Factor for Asthma? Lung India 2013;30:295-301.
[70] Su X, Ren Y, Li M, Zhao X, Kong L, Kang J. Association between Lipid Profile and the Prevalence of Asthma: A Meta-Analysis and Systemic Review. Curr Med Res Opin 2018;15:1207-18.
[71] Baumruker T, Csonga R, Pursch E, Pfeffer A, Urtz N, Sutton S, et al. Activation of Mast Cells by Incorporation of Cholesterol into Rafts. Int Immunol 2003;15:1207-18.
[72] Scalia R, Appel JZ, Lefer AM. Leukocyte-Endothelium Interaction during the Early Stages of Hypercholesterolemia in the Rabbit: Role of P-Selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol 1998;18:1093-100.
[73] Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, et al. Eosinophilic Inflammation in Asthma. N Engl J Med 1990;323:1033-9.